Position in IFRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$9,834
New position
Shares Held
11,000
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sanctuary Advisors, LLC holds $85,126,148 across 54 Biotechnology names. IFRX ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40,631 | $31,393,135 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,360 | $22,041,214 | |
| 3 | INSM |
INSMED Inc
|
23,969 | $3,919,410 | |
| 4 | EXEL |
Exelixis, Inc.
|
74,269 | $3,185,397 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
94,996 | $2,352,100 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,839 | $1,931,949 | |
| 7 | ARGX |
Argenx SE
|
2,432 | $1,775,968 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
27,324 | $1,713,214 |
All Filings in IFRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,834 | 11,000 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||